1460882419-a853f56d-64e2-43b8-8bdb-b6f6394b2162

1. An oral dosage form comprising
(i) a therapeutically effective amount of an opioid agonist;
(ii) naloxone or a pharmaceutically acceptable salt thereof in releasable form; and
(iii) sequestered naltrexone or a pharmaceutically acceptable salt thereof which is not substantially released when the dosage form is administered intact, but which is released in an amount sufficient to reduce or eliminate an analgesic or euphoric effect of the opioid when administered after the integrity of the dosage form has been compromised; and
(iv) a sustained release excipient;
wherein the opioid agonist, naloxone and the sequestered naltrexone are interdispersed in the sustained release excipient, and the sustained release excipient provides a sustained release of the opioid agonist and naloxone, and
the sequestered naltrexone is in the form of inert beads coated with naltrexone and overcoated with a sequestering material.
2. The dosage form of claim 1, which is aversive in physically dependent human subjects.
3. The dosage form of claim 1, wherein said sequestered naltrexone or a pharmaceutically acceptable salt thereof is dispersed in a matrix comprising the sustained release excipient.
4. The dosage form of claim 1 wherein said opioid is selected from the group consisting of morphine, hydromorphone, hydrocodone, oxycodone, codeine, levorphanol, tramadol, meperidine, methadone, pharmaceutically acceptable salts thereof and mixtures thereof.
5. The dosage form of claim 1 having a ratio of releasable naloxone or a pharmaceutically acceptable salt thereof to the opioid agonist that is analgesically effective when the combination is administered orally, but which is aversive in physically dependent human subjects when administered at the same amount or at a higher amount than said therapeutically effective amount.
6. The dosage form of claim 5 wherein said ratio of releasable naloxone or a pharmaceutically acceptable salt thereof to opioid agonist maintains an analgesic effect but does not increase analgesic efficacy of the opioid agonist relative to the same therapeutic amount of opioid analgesic when administered to human patients without said naloxone.
7. The oral dosage form of claim 1 wherein the naloxone or a pharmaceutically acceptable salt thereof is in an amount to attenuate a side effect of said opioid agonist selected from the group consisting of anti-analgesia, hyperalgesia, hyperexcitability, physical dependence, tolerance, and a combination of any of the foregoing.
8. The dosage form of claim 1, wherein the amount of naltrexone or a pharmaceutically acceptable salt thereof released during the dosing interval enhances the analgesic potency of the opioid agonist.
9. The dosage form of claim 7, wherein the amount of naloxone or a pharmaceutically acceptable salt thereof is about 100 to about 1000 fold less than the amount of the opioid agonist.
10. The dosage form of claim 2, wherein the ratio of the amount of naltrexone or a pharmaceutically acceptable salt thereof released from said dosage form after tampering to the amount of said naltrexone or a pharmaceutically acceptable salt thereof released from said intact dosage form is about 4:1 (w:w) or greater, based on the in-vitro dissolution at 1 hour of said dosage form in 900 ml of Simulated Gastric Fluid using a USP Type II (paddle) apparatus at 75 rpm at 37 degrees C.
11. The dosage form of claim 2, wherein the ratio of the amount of naltrexone or a pharmaceutically acceptable salt thereof contained in said intact dosage form to the amount of said naltrexone or a pharmaceutically acceptable salt thereof released from said intact dosage form after 1 hour is about 4:1 or greater, based on the in-vitro dissolution at 1 hour of said dosage form in 900 ml of Simulated Gastric Fluid using a USP Type II (paddle) apparatus at 75 rpm at 37 degrees C.
12. The oral dosage form of claim 10 wherein said ratio is 10:1 or greater.
13. The oral dosage form of claim 10 wherein said ratio is 50:1 or greater.
14. The oral dosage form of claim 10 wherein said ratio is 100:1 or greater.
15. A method of treating pain comprising administering a dosage form of claim 1.
16. A method of deterring abuse comprising preparing a dosage form of claim 1.
17. A method of preparing a dosage form of claim 1 comprising combining an opioid agonist with naloxone or a pharmaceutically acceptable salt thereof in releasable form and sequestered naltrexone or a pharmaceutically acceptable salt thereof in a dosage form.
18. An oral dosage form comprising
(i) a therapeutically effective amount of an opioid agonist;
(ii) naloxone or a pharmaceutically acceptable salt thereof in releasable form; and
(iii) sequestered naltrexone or a pharmaceutically acceptable salt thereof which is not substantially released when the dosage form is administered intact; and
(iv) a sustained release excipient;
wherein the ratio of the opioid agonist to sequestered naltrexone is such that an effect of the opioid agonist is at least partially blocked when (a) the dosage form is chewed, crushed or dissolved in a solvent, and (b) is administered orally, intranasally, parentrally or sublingually;
and the opioid agonist, naloxone and the sequestered naltrexone are interdispersed in the sustained release excipient, and the sustained release excipient provides a sustained release of the opioid agonist and naloxone, and the sequestered naltrexone is in the form of inert beads coated with naltrexone and overcoated with a sequestering material.
19. The dosage form of claim 18, wherein the amount of naloxone or a pharmaceutically acceptable salt thereof is about 100 to about 1000 fold less than the amount of the opioid agonist.
20. The dosage form of claim 1, wherein the opioid agonist, naloxone and the sequestered naltrexone are not isolated from each other in three distinct layers.
21. The dosage form of claim 18, wherein the opioid agonist, naloxone and the sequestered naltrexone are not isolated from each other in three distinct layers.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A two fabric hybrid type forming section for a paper making machine having a first forming fabric and at least one second forming fabric, such that:
(i) each of the forming fabrics has a paper side and a machine side;
(ii) the first forming fabric receives a layer of stock at an impingement point in a first open surface region, and thereafter passes in sequence through the first open surface region, a central forming zone and a second open surface region;
(iii) the second forming fabric passes through the central forming zone such that the paper side of the second forming fabric faces the paper side of the first forming fabric, and the two forming fabrics move together in the machine direction with a layer of stock sandwiched in between;
(iv) the forming fabrics are supported by a series of fabric support elements, chosen from the group consisting of rolls, static fabric support elements and both rolls and static fabric support elements, over which the machine sides of each of the forming fabrics pass in sliding contact, the fabric support elements being supported on a sequence of dewatering boxes, the dewatering boxes having a curved fabric support element supporting surface; and
(v) the dewatering boxes provide separate drainage zones and at least some of the dewatering boxes are connected to a source of vacuum to provide separate vacuum zones,

wherein:
(a) the dewatering boxes provide at least four separate and distinct vacuum zones within the central forming zone;
(b) the radii of curvature of the curved surfaces supporting the fabric support elements decrease progressively in the machine direction;
(c) a pitch of the fabric support elements decreases progressively in the machine direction; and
(d) the dewatering boxes supporting the fabric support elements are selectively located on the machine sides of the first forming fabric and the second forming fabric in opposed and at least partially offset sequence in the machine direction.
2. A forming section according to claim 1, wherein the pitch of successive fabric support elements within at least one vacuum zone decreases in the machine direction.
3. A forming section according to claim 1, wherein the fabric support elements have a width in the machine direction which decreases progressively in the machine direction.
4. A forming section according to claim 1, wherein the fabric support elements within at least one vacuum zone have a width in the machine direction which decreases progressively in the machine direction.
5. A forming section according to claim 1, wherein each dewatering box provides at least one vacuum zone.
6. A forming section according to claim 5, wherein at least one dewatering box provides at least two vacuum zones.
7. A forming section according to claim 6, wherein each dewatering box provides at least two vacuum zones.
8. A forming section according to claim 6, wherein in each dewatering box which provides at least two vacuum zones, the fabric support element pitch within successive vacuum zones provided by the dewatering box decreases in the machine direction.
9. A forming section according to claim 7, wherein in each dewatering box which provides at least two vacuum zones, the fabric support element pitch within successive vacuum zones provided by the dewatering box decreases in the machine direction.
10. A forming section according to claim 6, wherein in each dewatering box which provides at least two vacuum zones, the radii of curvature of the curved surfaces supporting the fabric support elements within successive vacuum zones provided by the dewatering box decreases in the machine direction.
11. A forming section according to claim 7, wherein in each dewatering box which provides at least two vacuum zones, the radii of curvature of the curved surfaces supporting the fabric support elements within successive vacuum zones provided by the dewatering box decreases in the machine direction.
12. A forming section according to claim 1, wherein the ratio of the width of the fabric support elements to the width of the gap between them varies from about 1:10 to about 1:0.5.
13. A forming section according to claim 1, wherein the forming section further includes a turning roll which is provided with vacuum assisted drainage.
14. A forming section according to claim 1, wherein the forming section further includes a turning roll without vacuum assisted drainage.